Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-25

Clinical Trial Update: Effects Of Berberine Plus Inulin On Diabetes Care in Patients With LADA [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effects of berberine plus inulin on diabetes care in patients with autoimmune Type 1 diabetes (LADA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Berberine (berberine)
  • Inulin (inulin)

Snippet

Sponsor: Second Xiangya Hospital of Central South University | Conditions: Type 1 Diabetes Mellitus, Autoimmune Diabetes | Phase 4 | Status: NOT_YET_RECRUITING